{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Global Approvals for Insulin Glargine Promise a More Affordable, Long-Acting Treatment for Diabetes",
    "url": "https://www.lexblog.com/2018/04/03/global-approvals-for-insulin-glargine-promise-a-more-affordable-long-acting-treatment-for-diabetes/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-MSMH5CTG",
        "url": "https://www.lexblog.com/lib/MSMH5CTG/"
    },
    "datePublished": "2018-04-03T18:59:32-04:00",
    "dateModified": "2021-11-09T08:40:19-05:00",
    "author": {
        "@type": "Person",
        "name": "Caitlin M. Wilmot"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Rothwell Figg"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Biosimilars Law Bulletin",
    "about": "Food, Drug & Agriculture",
    "sourceUrl": "http://www.biosimilarsip.com/?p=4321",
    "sourceStability": "may-move"
}